Clinical trial
Phase II Novel Low Cost QTc Meter for Long QT Syndrome Screening in Primary Care
NCT04441892 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Novel Low Cost QTc Meter for Long QT Syndrome Screening in Primary Care
- Lead sponsor
- Mayo Clinic
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- February 7, 2019
- Completion date
- March 26, 2020
- Enrollment
- 33 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.